Source: International Congress 2016 – Asthma points to ponder
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Yasuhito Suzuki (Fukushima-City, Japan), Yasuhito Suzuki, Junpei Saito, Manubu Uematsu, Atsuro Fukuhara, Suguru Sato, Ryuichi Togawa, Yuki Sato, Kenichi Misa, Takefumi Nikaido, Naoko Fukuhara, Xintao Wang, Yoshinori Tanino, Mitsuru Munakata. Clinical application of hydrogen sulfide (H2S) as a marker of asthma management. Eur Respir J 2016; 48: Suppl. 60, 3379

Member's Comments

No comment yet.

Related content which might interest you: Tiotropium for uncontrolled asthma (a meta-analysis) Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Epoxy and delayed asthma Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 Reproducibility and stability of severe asthma research program (SARP) clinical cluster phenotypes in SARP3 Source: International Congress 2016 – Phenotyping asthma Year: 2016 Asthma clusters in a real asthmatic population, treated in secondary medical care Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Priorities for asthma R&D in Europe: A systematic approach Source: International Congress 2016 – Asthma points to ponder Year: 2016 Occupational asthma due to cleaning agents Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis Year: 2013 An extensive function evaluation in severe asthma with airflow limitation Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 Occupational asthma due to cobalt in metal working fluid; a report of an outbreak Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis Year: 2013 Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Hydrogen sulphide as a biomarker in COPD and asthma Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma Source: Annual Congress 2013 –Genetic factors in airway development and disease Year: 2013 Application of clustering approach to occupational asthma due to isocyanates Source: International Congress 2015 – Work, environment and the epidemiology of asthma Year: 2015 Meta-analysis of the accuracy of screening adult asthma using exhaled nitric oxide Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 The multicomponent nature of difficult asthma Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Comparison of clinical features of severe persistent asthma and refractory asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Childhood obesity in relation to poor asthma control and exacerbations Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies Year: 2016 Asthma and the role of blood glucose monitoring Source: International Congress 2016 – Systemic biomarkers Year: 2016 Calv,NO and J’awNO in asthma. A multidimensional approach Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 LATE-BREAKING ABSTRACT: Disease control rate (DRC) of bronchial asthma during pregnancy Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013